Literature DB >> 13564268

Positron-scanning with copper-64 in the diagnosis of intracranial lesions: partition of copper-64 versenate in, and excretion from, the body.

H J BAGNALL, P BENDA, G L BROWNELL, W H SWEET.   

Abstract

Entities:  

Keywords:  BRAIN NEOPLASMS/diagnosis; COPPER/radioactive

Mesh:

Substances:

Year:  1958        PMID: 13564268     DOI: 10.3171/jns.1958.15.4.0411

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


× No keyword cloud information.
  6 in total

1.  [INVESTIGATIONS ON THE DISTRIBUTION OF RADIOISOTOPES USED FOR BRAIN TUMOR DIAGNOSIS IN THE BLOOD CIRCULATION, IN EXPERIMENTAL TUMORS AND HUMAN BRAIN TUMORS].

Authors:  F MUNDINGER; H GERHARD
Journal:  Acta Neurochir (Wien)       Date:  1963-11-21       Impact factor: 2.216

2.  [Brain tumor diagnosis with positron rays].

Authors:  O WILCKE
Journal:  Acta Neurochir (Wien)       Date:  1962-05-28       Impact factor: 2.216

3.  A practical guide to the construction of radiometallated bioconjugates for positron emission tomography.

Authors:  Brian M Zeglis; Jason S Lewis
Journal:  Dalton Trans       Date:  2011-03-25       Impact factor: 4.390

4.  Intracranial extension of a non-striated embryonal rhabdomyosarcoma of the orbit.

Authors:  D Sevel
Journal:  Br J Ophthalmol       Date:  1969-03       Impact factor: 4.638

5.  Inhibition of angiogenesis and tumor growth in the brain. Suppression of endothelial cell turnover by penicillamine and the depletion of copper, an angiogenic cofactor.

Authors:  S S Brem; D Zagzag; A M Tsanaclis; S Gately; M P Elkouby; S E Brien
Journal:  Am J Pathol       Date:  1990-11       Impact factor: 4.307

6.  Use of radioactive arsenic (As74) in the diagnosis of suvatentorial brain tumours.

Authors:  E H BOTTERELL; W M LOUGHEED; T P MORLEY; R R TASKER
Journal:  Can Med Assoc J       Date:  1961-12-16       Impact factor: 8.262

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.